Interventional Radiology Imaging

What Is the Best Initial Procedure for Suspected Sclerosing Cholangitis? An ACR Workflow

·
What Is the Best Initial Procedure for Suspected Sclerosing Cholangitis? An ACR Workflow

A 45-year-old patient presents with progressive jaundice, debilitating pruritus, and fatigue. Liver function tests show a marked cholestatic pattern with a significantly elevated total bilirubin and alkaline phosphatase. An initial ultrasound was non-specific, showing mild intrahepatic ductal dilation but no obvious stone or mass. You suspect an inflammatory cholangiopathy like sclerosing cholangitis and need to decide on the initial therapeutic intervention. This is a common and complex decision point where diagnostic and therapeutic goals intersect. This article provides a detailed workflow for this specific scenario, clarifying the American College of Radiology (ACR) recommendation for the initial procedure. For a patient with elevated bilirubin and suspected sclerosing cholangitis, the ACR rates an Endoscopic internal biliary catheter (removable plastic stent) as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies specifically to patients presenting with clinical and biochemical evidence of biliary obstruction (e.g., elevated bilirubin, alkaline phosphatase) where sclerosing cholangitis is a leading diagnostic consideration. This is often a patient with a history of inflammatory bowel disease (IBD), particularly ulcerative colitis, but can also occur as a primary diagnosis. The key feature is the suspicion of a chronic, fibrosing inflammatory process causing multiple strictures throughout the biliary tree, rather than a single, discrete point of obstruction.

This workflow is distinct from other causes of biliary obstruction. It should not be applied to patients where the primary suspicion is:

  • Acute Cholangitis or Biliary Sepsis: These patients are acutely ill with fever, right upper quadrant pain, and jaundice (Charcot’s triad) and require emergent biliary drainage, which may involve different procedural considerations.
  • Malignant Obstruction: If a discrete mass, such as a pancreatic head tumor or a hilar cholangiocarcinoma (Klatskin tumor), is seen on prior imaging, the therapeutic approach and stenting strategy are fundamentally different.
  • Choledocholithiasis: A patient with a clear stone identified in the common bile duct on ultrasound or MRCP requires stone extraction, which is a different therapeutic goal than managing inflammatory strictures.

This article focuses on the initial therapeutic step, which in the case of sclerosing cholangitis, is often intertwined with the definitive diagnostic procedure.

What Diagnoses Are You Working Up in This Scenario?

When a patient presents with suspected sclerosing cholangitis, the primary goal is to confirm the diagnosis, assess the extent and severity of biliary stricturing, and rule out mimics or complications. The differential diagnosis guides the procedural strategy.

Primary Sclerosing Cholangitis (PSC): This is the most common consideration. It is a chronic, progressive cholestatic liver disease characterized by inflammation and fibrosis of the intrahepatic and/or extrahepatic bile ducts. The classic cholangiographic appearance is multifocal, short, annular strictures alternating with normal or slightly dilated segments, creating a “beads on a string” appearance. Obtaining a cholangiogram is essential for diagnosis.

Secondary Sclerosing Cholangitis: This category includes cholangiopathies that mimic PSC but result from a known secondary cause. It is critical to consider these, as their management can differ. Causes include ischemic injury (e.g., post-liver transplant, hepatic artery thrombosis), recurrent pyogenic cholangitis, infectious cholangitis (especially in immunocompromised patients), and intraductal stone disease.

IgG4-Associated Cholangitis (IAC): A key mimic of PSC, IAC is the biliary manifestation of IgG4-related systemic disease. It responds well to corticosteroids, making its differentiation from PSC crucial. Cholangiography can be similar, but biopsies and serum IgG4 levels are key discriminators.

Cholangiocarcinoma: The most feared complication and differential diagnosis. PSC is a major risk factor for developing cholangiocarcinoma. Any dominant, high-grade stricture identified during the workup must be aggressively evaluated with brush cytology and/or biopsy to rule out underlying malignancy, as this dramatically alters prognosis and management.

Why Is an Endoscopic Internal Biliary Catheter the Recommended Initial Procedure?

For a patient with elevated bilirubin and suspected sclerosing cholangitis, the ACR designates an Endoscopic internal biliary catheter (removable plastic stent) via Endoscopic Retrograde Cholangiopancreatography (ERCP) as Usually appropriate. This procedure serves a dual purpose: it is the gold standard for diagnosing the condition via direct cholangiography and allows for immediate therapeutic intervention.

The primary rationale is the ability to both visualize the biliary tree and treat a “dominant stricture”—a clinically significant, high-grade narrowing that is the primary driver of the patient’s cholestasis. During ERCP, a cholangiogram is performed to map the strictures. If a dominant stricture is found, it can be dilated with a balloon and then stented with a temporary, removable plastic stent. This re-establishes bile flow, relieves the jaundice and pruritus, and reduces the risk of bacterial cholangitis. Tissue sampling (brushings or biopsies) can also be performed to rule out cholangiocarcinoma.

Alternative procedures are rated lower for this specific initial presentation:

  • Percutaneous internal/external biliary catheter: Rated May be appropriate. This approach, known as Percutaneous Transhepatic Cholangiography (PTC), is more invasive, involving a needle puncture through the liver into the biliary system. It is typically reserved for cases where ERCP is technically unsuccessful or anatomically impossible (e.g., in patients with surgically altered anatomy like a Roux-en-Y gastric bypass).
  • Permanent biliary metallic stent: Rated Usually not appropriate. Metallic stents are designed for palliative drainage in patients with malignant obstruction and a limited life expectancy. Placing one for a benign, chronic inflammatory condition like PSC is inappropriate. They can be difficult or impossible to remove and can interfere with future therapeutic options, including liver transplantation.
  • Surgery: Rated Usually not appropriate as an initial therapeutic step. Surgical intervention is reserved for managing complications of PSC or for liver transplantation in end-stage disease, not for primary management of biliary strictures.

These procedures involve fluoroscopy, which uses ionizing radiation. The specific radiation relative level (RRL) is not defined by the ACR for these interventional procedures, but the dose should always be kept as low as reasonably achievable.

What’s Next After an Endoscopic Biliary Catheter Placement? Downstream Workflow

The results of the initial ERCP and stenting procedure dictate the subsequent management plan. The workflow is not a one-time fix but the beginning of long-term management for a chronic disease.

If a dominant stricture is stented successfully: The patient’s bilirubin and cholestatic enzymes should improve. The key next step is scheduling a repeat ERCP for stent exchange in approximately 3-4 months. Plastic stents will eventually clog, and leaving them in place for too long risks stent occlusion and severe cholangitis. The patient will also be managed medically, often with ursodeoxycholic acid, and monitored for complications of PSC and IBD.

If cholangiography shows diffuse stricturing without a clear dominant stricture: In this case, stenting may not be beneficial or technically feasible. The primary outcome of the procedure is diagnostic. Brushings and biopsies are still obtained. The patient’s management will be primarily medical, focusing on symptom control and monitoring for disease progression and the development of cholangiocarcinoma through surveillance imaging (e.g., annual MRCP and/or ultrasound).

If findings are suspicious for malignancy: If brush cytology or biopsies from a stricture are positive or highly suspicious for cholangiocarcinoma, the patient’s entire management changes. This triggers a full oncologic staging workup and discussion at a multidisciplinary tumor board to determine resectability and further treatment, which may involve chemotherapy, radiation, or consideration for a different type of biliary stent (e.g., a covered metal stent).

If the endoscopic procedure is unsuccessful: If the endoscopist cannot access the biliary tree, the next step is often to consult Interventional Radiology for a percutaneous approach (PTC) to achieve biliary drainage and cholangiography.

Pitfalls to Avoid (and When to Get Help)

Navigating the initial management of suspected sclerosing cholangitis requires careful consideration to avoid common errors. Be aware of these potential pitfalls:

  • Assuming all strictures are benign: The highest-risk pitfall is missing a concurrent cholangiocarcinoma. Any dominant or particularly suspicious stricture must be aggressively sampled.
  • Placing the wrong type of stent: Using a permanent, uncovered self-expanding metal stent in a benign condition like PSC is a significant error that can complicate future treatment.
  • Forgetting post-ERCP pancreatitis: This is the most common complication of ERCP. Ensure the patient is appropriately monitored post-procedure and counseled on the risk.
  • Losing the patient to follow-up: A plastic biliary stent is a temporary device. Failing to schedule and perform a timely stent exchange is a setup for stent occlusion and life-threatening cholangitis.

Escalate immediately to a gastroenterologist or interventional radiologist if the patient develops signs of acute cholangitis (fever, rigors, worsening jaundice) or if initial attempts at biliary access are unsuccessful.

Related ACR Topics and Tools

This article covers a single, specific clinical scenario. For a comprehensive overview of all variants and procedural ratings, or to explore tools for other clinical questions, the following resources are essential.

Frequently Asked Questions

Why is a removable plastic stent preferred over a metal stent for sclerosing cholangitis?

Sclerosing cholangitis is a benign (non-cancerous) inflammatory condition, though it carries a risk of future cancer. Plastic stents are temporary and removable, allowing for repeated interventions and adjustments as the disease evolves. Permanent metal stents are designed for malignant obstruction with a limited life expectancy and can cause complications that preclude future options like surgery or liver transplantation.

What is the role of MRCP before performing an ERCP in this scenario?

Magnetic Resonance Cholangiopancreatography (MRCP) is a non-invasive imaging technique that is excellent for mapping the biliary tree. It is often performed before ERCP to confirm the diagnosis of sclerosing cholangitis, identify the location of dominant strictures, and rule out other causes. This allows the endoscopist to plan the therapeutic ERCP more effectively.

How often do plastic biliary stents need to be exchanged?

As a general rule, plastic biliary stents should be electively exchanged every 3 to 4 months. Leaving them in longer significantly increases the risk of the stent becoming clogged with biliary sludge, leading to bacterial colonization, obstruction, and acute cholangitis.

How does a history of inflammatory bowel disease (IBD) affect this diagnosis?

There is a very strong association between Primary Sclerosing Cholangitis (PSC) and IBD, particularly ulcerative colitis. In a patient with IBD who develops a cholestatic liver enzyme profile, PSC should be one of the top diagnostic considerations. The presence of IBD increases the clinical suspicion for PSC.

Is ERCP with stenting a cure for sclerosing cholangitis?

No, it is not a cure. Sclerosing cholangitis is a chronic, progressive disease for which the only definitive cure is liver transplantation. ERCP with balloon dilation and stenting is a therapeutic intervention aimed at managing a dominant stricture to relieve biliary obstruction, improve symptoms, and prevent cholangitis. It is a key part of the long-term management strategy, not a curative procedure.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026